Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Insulins | Case report

Nivolumab

Autoimmune-mediated insulin dependent diabetes mellitus

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Abid H, et al. Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus. Journal of the Endocrine Society 13 (Suppl. 1): abstr. SUN-LB036, May 2019. Available from: URL: https://dx.doi.org/10.1210/js.2019-SUN-LB036 [abstract] Abid H, et al. Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus. Journal of the Endocrine Society 13 (Suppl. 1): abstr. SUN-LB036, May 2019. Available from: URL: https://​dx.​doi.​org/​10.​1210/​js.​2019-SUN-LB036 [abstract]
Metadata
Title
Nivolumab
Autoimmune-mediated insulin dependent diabetes mellitus
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52112-9

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Tozinameran

Case report

Daratumumab

Case report

Heparin

Case report

Zolpidem